0001751998-23-000002.txt : 20230731 0001751998-23-000002.hdr.sgml : 20230731 20230731135451 ACCESSION NUMBER: 0001751998-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230731 DATE AS OF CHANGE: 20230731 EFFECTIVENESS DATE: 20230731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redona Therapeutics, Inc. CENTRAL INDEX KEY: 0001751998 IRS NUMBER: 811868742 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-488348 FILM NUMBER: 231126447 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 100B CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-603-6060 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 100B CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Twentyeight-Seven, Inc. DATE OF NAME CHANGE: 20180905 D 1 primary_doc.xml X0708 D LIVE 0001751998 Redona Therapeutics, Inc. 490 ARSENAL WAY SUITE 100B WATERTOWN MA MASSACHUSETTS 02472 617-603-6060 DELAWARE Twentyeight-Seven, Inc. Corporation true Kazumi Shiosaki 490 Arsenal Way Suite 100B Watertown MA MASSACHUSETTS 02472 Executive Officer Director Luke Evnin 490 Arsenal Way Suite 100B Watertown MA MASSACHUSETTS 02472 Director Michal Silverberg 490 Arsenal Way Suite 100B Watertown MA MASSACHUSETTS 02472 Director Christine Brennan 490 Arsenal Way Suite 100B Watertown MA MASSACHUSETTS 02472 Director Henrijette Richter 490 Arsenal Way Suite 100B Watertown MA MASSACHUSETTS 02472 Director Biotechnology Decline to Disclose 06b false 2023-07-21 false true false 0 11907796 5953898 5953898 false 8 0 0 0 false Redona Therapeutics, Inc. /s/ Kazumi Shiosaki Kazumi Shiosaki President and Chief Executive Officer 2023-07-31